Study ID: IXR-205-21-189

Study Title

Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

Teva Identifier

IXR-205-21-189

ClinicalTrials.gov Identifier

NCT00062504

Study Status

Terminated

Trial Condition(s)

Glioblastoma Multiforme | Anaplastic Astrocytoma|Anaplastic Oligodendroglioma | Anaplastic Mixed Oligoastrocytoma

Interventions

Drug: Talampanel

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
cancer icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years and older

Trial Duration

07/01/2003 - 04/01/2006

Phase

Phase 2

Study Type

Interventional